Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/ II Clinical Trial in Progress

Shotaro Hagiwara, MD PhD, Yan-Hua Wang, MD, Hirohito Kobayashi, MD, Yutaka Kato, MD, Norina Tanaka, MD PhD, Yuki Iizuka, MD, Aya Watanabe, MD, Midori Ishiyama, MD PhD, Akihito Shinohara, MD PhD, Hiroshi Kazama, MD PhD, Kentaro Yoshinaga, MD PhD, Masayuki Shiseki, MD PhD, Hitoshi Kanno, MD PhD, Junji Tanaka, MD PhD

Blood (2019) 134 (Supplement_1): 3133.

https://doi.org/10.1182/blood-2019-127739

Published: 2019

Journal Articles

An Ongoing Global, Longitudinal, Observational Study of Patients with Pyruvate Kinase Deficiency: The PEAK Registry

Rachael F. Grace, MD, Paola Bianchi, BSc, PhD, Bertil Glader, MD PhD, Andreas Glenthøj, MD PhD, Bryan Jones, PhD, Hitoshi Kanno, MD PhD, Kevin H. M. Kuo, MDMSc,FRCPC, D. Mark Layton, MB ChB, Eduard J. van Beers, MD PhD, Joan-Lluis Vives Corrons, MD PhD, Tu Xu, MS, PhD

Blood (2019) 134 (Supplement_1): 2223.

https://doi.org/10.1182/blood-2019-123059

Published: 2019

Journal Articles

Generation and Functional Analysis of Congenital Dyserythropoietic Anemia (CDA) Patient-Specific Induced Pluripotent Stem Cells

Hiroshi Kohara, PhD, Hiromi Ogura, MD PhD, Takako Aoki, MLS, Chika Sakamoto, Yoshie Ogawa, Shohei Miyamoto, PhD, Hitoshi Kanno, MD PhD, Kenzaburo Tani, MD PhD

Blood (2016) 128 (22): 2426.

https://doi.org/10.1182/blood.V128.22.2426.2426

Published: 2016

Journal Articles

The Novel Missense Mutation of GATA1 Caused Red Cell Adenosine Deaminase Overproduction Associated with Congenital Hemolytic Anemia

Hiromi Ogura, MD PhD, Toshiyuki Yamamoto, MD PhD, Taiju Utsugisawa, MD PhD, Takako Aoki, MLS, Takuya Iwasaki, MLS, Yumiko Ondo, MLS, Takahiro Kawakami, MD PhD, Shinichiro Nakagawa, MD PhD, Shuichi Ozono, MD PhD, Hiroko Inada, MD PhD, Hitoshi Kanno, MD PhD

Blood (2016) 128 (22): 400.

https://doi.org/10.1182/blood.V128.22.400.400

Published: 2016

Journal Articles

COL4A1 is a Novel Causative Gene Responsible for Congenital Hemolytic Anemia, Representing Characteristic Clinical Course in Infants

Hiromi Ogura, MD PhD, Shouichi Ohga, MD PhD, Takako Aoki, MLS, Taiju Utsugisawa, MDPhD, Hidehiro Takahashi, MDPhD, Asayuki Iwai, Kenichiro Watanabe, MD PhD, Yusuke Okuno, MD PhD, Kenichi Yoshida, MD PhD, Satoru Miyano, MD PhD, Seishi Ogawa, MD PhD, Seiji Kojima, MD PhD, Hitoshi Kanno, MD PhD

Blood (2015) 126 (23): 934.

https://doi.org/10.1182/blood.V126.23.934.934

Published: 2015

Journal Articles

ATP11C Encodes a Major Flippase in Human Erythrocyte and Its Genetic Defect Causes Congenital Non-Spherocytic Hemolytic Anemia

Nobuto Arashiki, PhD, Yuichi Takakuwa, MD PhD, Hiromi Ogura, MD PhD, Taiju Utsugisawa, MDPhD, Satoru Miyano, MD PhD, Seishi Ogawa, MD PhD, Seiji Kojima, MD PhD, Shouichi Ohga, MD PhD, Narla Mohandas, DSc, Hitoshi Kanno, MD PhD

Blood (2015) 126 (23): 2131.

https://doi.org/10.1182/blood.V126.23.2131.2131

Published: 2015

Journal Articles

Identification of Two New DBA Genes, RPS27 and RPL27 , by Whole-Exome Sequencing in Diamond-Blackfan Anemia Patients

Blood (2012) 120 (21): 984.

https://doi.org/10.1182/blood.V120.21.984.984

Published: 2012

Journal Articles

Target Marker Gene Expressions and the Possibility of Molecular Therapy for Children’s Brain Tumors.

Toshihisa Tsuruta, MD, PhD, Hitoshi Kanno, MD, PhD, Yasuo Aihara, MD, PhD, Takako Hamada, MD, PhD, Masako Sakauchi, MD, PhD, Makiko Osawa, MD, PhD, Emiko Wada, MD, PhD, Osami Kubo, MD, PhD, Tomokatsu Hori, MD, PhD, Hisaichi Fujii, MD, PhD

Blood (2006) 108 (11): 5468.

https://doi.org/10.1182/blood.V108.11.5468.5468

Published: 2006

Journal Articles

Alpha Hemoglobin Stabilizing Protein (AHSP) Is a Susceptibility Gene to Drug /Infection-Induced Hemolytic Anemia.

Hitoshi Kanno, MD, PhD, Naoyuki Kamatani, MD, PhD, Takako Hamada, Kaori Furihata, PhD, Yukio Hattori, MD, PhD, Shiro Miwa, MD, PhD, Hisaichi Fujii, MD, PhD

Blood (2005) 106 (11): 1678.

https://doi.org/10.1182/blood.V106.11.1678.1678

Published: 2005

Journal Articles

Ex Vivo Treatment of Erythroid Cells with Glycolytic Intermediates for Metabolic Correction of Pyruvate Kinase Deficiency.

Hitoshi Kanno, MD PhD, Ken-ichi Aisaki, MD PhD, Takako Hamada, Shin-ichi Okada, Hisaichi Fujii, MD PhD

Blood (2004) 104 (11): 3689.

https://doi.org/10.1182/blood.V104.11.3689.3689

Published: 2004

NARROW

Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/ II Clinical Trial in Progress

An Ongoing Global, Longitudinal, Observational Study of Patients with Pyruvate Kinase Deficiency: The PEAK Registry

Generation and Functional Analysis of Congenital Dyserythropoietic Anemia (CDA) Patient-Specific Induced Pluripotent Stem Cells

The Novel Missense Mutation of GATA1 Caused Red Cell Adenosine Deaminase Overproduction Associated with Congenital Hemolytic Anemia

COL4A1 is a Novel Causative Gene Responsible for Congenital Hemolytic Anemia, Representing Characteristic Clinical Course in Infants

ATP11C Encodes a Major Flippase in Human Erythrocyte and Its Genetic Defect Causes Congenital Non-Spherocytic Hemolytic Anemia

Identification of Two New DBA Genes, RPS27 and RPL27 , by Whole-Exome Sequencing in Diamond-Blackfan Anemia Patients

Target Marker Gene Expressions and the Possibility of Molecular Therapy for Children’s Brain Tumors.

Alpha Hemoglobin Stabilizing Protein (AHSP) Is a Susceptibility Gene to Drug /Infection-Induced Hemolytic Anemia.

Ex Vivo Treatment of Erythroid Cells with Glycolytic Intermediates for Metabolic Correction of Pyruvate Kinase Deficiency.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only